Winifred L. Swan, SVP and General Counsel at NxStage Medical, Inc. (NXTM), sold 620 shares at $19.04 ($12K) on 2016-01-14, disclosed to the SEC on 2016-01-15.
Scheduled sale ($12k) by SVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NXTM | SELL | 2017-12-21 | $89K | — | Filing → |
| NXTM | SELL | 2017-11-15 | $90K | — | Filing → |
| NXTM | SELL | 2017-10-23 | $96K | — | Filing → |